BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29578129)

  • 1. DNA Methylation and Uveal Melanoma.
    Yang ZK; Yang JY; Xu ZZ; Yu WH
    Chin Med J (Engl); 2018 Apr; 131(7):845-851. PubMed ID: 29578129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Epigenetics in Uveal Melanoma.
    Li Y; Jia R; Ge S
    Int J Biol Sci; 2017; 13(4):426-433. PubMed ID: 28529451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
    Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of RASSF1a in uveal melanoma.
    Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.
    Venza M; Visalli M; Biondo C; Lentini M; Catalano T; Teti D; Venza I
    Biochim Biophys Acta; 2015 Mar; 1849(3):247-56. PubMed ID: 25497382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of RASSF1A in uveal melanocytes and melanoma cells.
    Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
    Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of CpG island promoters in uveal melanoma.
    Moulin AP; Clément G; Bosman FT; Zografos L; Benhattar J
    Br J Ophthalmol; 2008 Feb; 92(2):281-5. PubMed ID: 18211945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.
    Herlihy N; Dogrusöz M; van Essen TH; Harbour JW; van der Velden PA; van Eggermond MC; Haasnoot GW; van den Elsen PJ; Jager MJ
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1447-58. PubMed ID: 25593028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial intratumor heterogeneity in uveal melanoma: Tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction.
    Herwig-Carl MC; Sharma A; Höller T; Holz FG; Schlitter AM; Loeffler KU
    Exp Eye Res; 2019 May; 182():175-181. PubMed ID: 30954503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of RASSF1A in uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
    Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
    BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomethylation of CD3D promoter induces immune cell infiltration and supports malignant phenotypes in uveal melanoma.
    Zhang C; Wu S
    FASEB J; 2023 Oct; 37(10):e23128. PubMed ID: 37651092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA m
    Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
    J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide aberrant methylation in primary metastatic UM and their matched metastases.
    Smit KN; Boers R; Vaarwater J; Boers J; Brands T; Mensink H; Verdijk RM; van IJcken WFJ; Gribnau J; de Klein A; Kilic E
    Sci Rep; 2022 Jan; 12(1):42. PubMed ID: 34997020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathological and molecular genetic characteristics in patients with extrabulbar growth of uveal melanoma].
    Saakyan SV; Khoroshilova-Maslova IP; Tsygankov АY; Amiryan АG; Isaeva RТ
    Arkh Patol; 2016; 78(4):20-26. PubMed ID: 27600778
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Horvathova Kajabova V; Soltysova A; Demkova L; Plesnikova P; Lyskova D; Furdova A; Babal P; Smolkova B
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.